Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-05

AUTHORS

Alexandra C. McPherron, Ann M. Lawler, Se-Jin Lee

ABSTRACT

The transforming growth factor-β (TGF-β) superfamily encompasses a large group of growth and differentiation factors playing important roles in regulating embryonic development and in maintaining tissue homeostasis in adult animals1. Using degenerate polymerase chain reaction, we have identified a new murine TGF-β family member, growth/differentiation factor-8 (GDF-8), which is expressed specifically in developing and adult skeletal muscle. During early stages of embryogenesis, GDF-8 expression is restricted to the myotome compartment of developing somites. At later stages and in adult animals, GDF-8 is expressed in many different muscles throughout the body. To determine the biological function of GDF-8, we disrupted the GDF-8 gene by gene targeting in mice. GDF-8 null animals are significantly larger than wild-type animals and show a large and widespread increase in skeletal muscle mass. Individual muscles of mutant animals weigh 2-3 times more than those of wild-type animals, and the increase in mass appears to result from a combination of muscle cell hyperplasia and hypertrophy. These results suggest that GDF-8 functions specifically as a negative regulator of skeletal muscle growth. More... »

PAGES

83-90

Journal

TITLE

Nature

ISSUE

6628

VOLUME

387

Related Patents

  • Methods To Identify Growth Differentiation Factor (Gdf) Receptors
  • Antibody To Gdf8 And Uses Thereof
  • Controlled Delivery Of Tlr Agonists In Structural Polymeric Devices
  • Modulate Myostatin Signal Transduction; Obesity
  • Therapeutic Methods For Muscular Or Neuromuscular Disorders
  • Oligomers
  • Method Of Promoting Bone Growth By An Anti-Actriia Antibody
  • Use Of Myostatin Inhibitors And Combination Therapies
  • Methods And Compositions For Improving Skeletal Muscle Protein Fractional Synthetic Rate
  • Myostatin Inhibitor Comprising Extracellular Water-Soluble Domains Of Dlk1 As Active Ingredient
  • Nucleic Acid Sequence Encodes A Polypeptide That Regulates Muscle Cell Growth
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Compositions And Methods For The Treatment Of Muscle Wasting
  • Isolated Polynucleotide That Encodes An Actriia-Fc Fusion Polypeptide
  • Method Of Enriching For Pancreatic Endoderm Cells
  • Relate To Various Cell Proliferative Disorders, Especially Those Involving Muscle, Nerve, And Adipose Tissue
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Modified And Stabilized Gdf Propeptides And Uses Thereof
  • Immunoglobulin Against Growth Differentiation Factor -8 (Gdf-8) For Use In The Prevention And Treatment Of Bone, Muscular, Nervous System And Obesity; Muscle Enhancement
  • Scaffolds For Cell Transplantation
  • Methods For Increasing Lean Body Mass With Resistance Training And A Gdf8 Inhibitor That Is An Anti-Gdf8 Antibody
  • Anti-Activin A Antibodies And Uses Thereof
  • Methods For Increasing Thermogenic Adipocytes
  • Method For Treating Muscular Dystrophy Using Antagonist Antibodies Against Gdf-8
  • Method For Treating Muscle Wasting Syndrome Using Antagonist Antibodies Against Gdf-8
  • Anti-Activin A Antibodies And Uses Thereof
  • Injectable Cryogel Vaccine Devices And Methods Of Use Thereof
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Mesoporous Silica Compositions Comprising Inflammatory Cytokines Comprising Inflammatory Cytokines For Modulating Immune Responses
  • Method For Down-Regulating Gdf-8 Activity
  • Continuous Cell Programming Devices
  • Oligomers
  • Method Of Increasing Muscle Mass By Administering A Myostatin Binding Agent
  • Methods For Increasing Red Blood Cell Levels And Treating Anemia Using A Combination Of Gdf Traps And Erythropoietin Receptor Activators
  • Using Bone Morphogenic Protein Specific Immunoglobulin For Treatment And Prevention Of Osteopenia, Osteomalacia, Osteoporosis, Osteomyeloma, Osteodystrophy And Paget's Disease
  • Injectable, Pore-Forming Hydrogels For Materials-Based Cell Therapies
  • Activin Receptor Type Iia Variants And Methods Of Use Thereof
  • Gasp1: A Follistatin Domain Containing Protein
  • Polynucleotides Encoding Antagonist Antibodies Against Gdf-8
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Antigen-Binding Molecule Capable Of Binding Two Or More Antigen Molecules Repeatedly
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Antisense-Induced Exon Exclusion In Myostatin
  • Polynucleotides Encoding Myostatin Binding Agents
  • Activin Receptor Type Iia Variants And Methods Of Use Thereof
  • Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels
  • Activin-Actriia Antagonists For Treating A Follicle-Stimulating Horomone-Secreting Pituitary Tumor
  • Oligonucleotide Probes; Hybridization; Polynucleotides; Use For Modulating Muscle Cell And Adipose Tissue Growth And Detection Of Cell Proliferative Disorder Of Muscle, Nerve Or Fat Tissues
  • Oligomers
  • Methods Of Increasing Muscle Mass Using Follistatin-Like Related Gene (Flrg)
  • Myostatin Gene Promoter And Inhibition Of Activation Thereof
  • Gasp1: A Follistatin Domain Containing Protein
  • Fc Region Variant
  • Activin-Actriia Antagonists And Uses For Treating Or Preventing Breast Cancer
  • Methods For Increasing Thermogenic Adipocytes
  • Using Allelic Variation To Differentiate Animal Products On Basis Of Breed Origin
  • For Increasing Muscle Synthesis And Treating Disease In Vertebrate Subjects, For Reducing Myostatin Activity
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Materials Presenting Notch Signaling Molecules To Control Cell Behavior
  • Scaffolds For Cell Transplantation
  • Combination Vaccine Devices And Methods Of Killing Cancer Cells
  • Neutralizing Antibodies Against Gdf-8 And Uses Therefor
  • Isolated Nucleic Acid Molecule Encoding An Antibody That Reduces Gdf-8 Activity
  • Activin-Actrii Antagonists And Uses For Increasing Red Blood Cell Levels
  • Variants Derived From Actriib And Uses Therefor
  • Double-Muscling In Mammals
  • Methods For Enriching For Pancreatic Endocrine Cells
  • Anti-Myostatin Antibodies
  • Scaffolds For Cell Transplantation
  • Compositions And Methods For Increasing Muscle Mass And Muscle Strength By Specifically Antagonizing Gdf8 And Or Activin A
  • Activin-Actriia Antagonists And Uses For Decreasing Or Inhibiting Fsh Secretion
  • Isolated Cell Comprising A Nucleic Acid Encoding Antibody Inhibitors Of Gdf-8 And Uses Thereof
  • Use Of Follistatin To Increase Muscle Mass
  • Isolated Activin-Binding Actriia Polypeptide Comprising The Seq Id No: 7 And Uses For Promoting Bone Growth
  • Growth Differentiation Factor-8
  • Gasp1: A Follistatin Domain Containing Protein
  • Controlled Release Of Growth Factors And Signaling Molecules For Promoting Angiogenesis
  • Proteolytic Fragment Of A Growth Differentiation Factor (Gdf) Polypeptide (Pro-Gdf) Or A Functional Peptide Portion Thereof; Affects Activity Associated With Gdf Signal Transduction
  • Method Of Promoting Bone Growth By An Anti-Activin B Antibody
  • Anti-Myostatin Antibodies
  • Compositions And Methods For Identifying And Testing Tgf-Β Pathway Agonists And Antagonists
  • Administering Inhibitors Of Tgfbeta Signaling, Benzothiazepine Derivatives Or Combinations Thereof To Improve Muscle Function In Cancer Patients
  • Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Methods And Compositions For Improving Skeletal Muscle Protein Fractional Synthetic Rate
  • Activin-Actriia Antagonists And Uses For Treating Multiple Myeloma
  • Growth Differentiation Factor-8 Nucleic Acid And Polypeptide From Aquatic Species, And Transgenic Aquatic Species
  • Premature Peptide For Use In Treatment Of Nervous System, Muscular, Heart, Diabetic And Bone Disorders
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Mesoporous Silica Compositions For Modulating Immune Responses
  • Use Of Decorin For Increasing Muscle Mass
  • Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
  • Activin-Actrii Antagonists And Uses For Treating Bone And Other Disorders
  • Cell-Friendly Inverse Opal Hydrogels For Cell Encapsulation, Drug And Protein Delivery, And Functional Nanoparticle Encapsulation
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Antibody To Gdf8 And Uses Thereof
  • Immune Cell Trapping Devices And Methods For Making And Using The Same
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Uses Of Growth And Differentiation Factor 8 (Gdf-8)
  • Cell-Friendly Inverse Opal Hydrogels For Cell Encapsulation, Drug And Protein Delivery, And Functional Nanoparticle Encapsulation
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Activin-Actriia Antagonists And Uses For Promoting Bone Growth
  • Injectable Preformed Macroscopic 3-Dimensional Scaffolds For Minimally Invasive Administration
  • Co-Delivery Of Stimulatory And Inhibitory Factors To Create Temporally Stable And Spatially Restricted Zones
  • Method For Predicting Athletic Performance Potential
  • Plant Virus Coat Fusion Proteins With Gdf8 Epitopes And Vaccines Thereof
  • Polypeptides; Proteolysis Splitting; Antitumor Agents
  • Scaffolds For Cell Transplantation
  • Antibody To Gdf8 And Uses Thereof
  • Growth Differentiation Factor-8
  • Methods For Screening Compounds For Increasing Thermogenic Adipocytes
  • Immune Cell Trapping Devices And Methods For Making And Using The Same
  • Controlled Release Of Growth Factors And Signaling Molecules For Promoting Angiogenesis
  • Increasing The Muscle Mass In An Animal By Administering An Antibody, Or Antigen-Binding Fragment Of Said Antibody, Which Binds To And Inhibits The Activity Of Gdf-8 Polypeptide
  • Premature Peptide For Use In Treatment Of Nervous System, Muscular, Heart, Diabetic And Bone Disorders
  • Activin-Actrii Antagonists And Uses For Treating Bone And Other Disorders
  • Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
  • Methods For Purifying Endoderm And Pancreatic Endoderm Cells Derived From Human Embryonic Stem Cells
  • Isolated Gdf Trap Polypeptide
  • Method For Producing An Actriib-Fc Fusion Polypeptide
  • Polypeptide Comprises Amino Acid Sequences Having Point Mutations Of Cleavage Sites For Metalloenzymes, Used For Prophylaxis Of Metabolic And Muscular Disorders; Bone Morphogenetic Protein/Tolloid Or Tolloid-Like Protein Complexes
  • Programming Of Cells For Tolerogenic Therapies
  • Method Of Increasing Red Blood Cell Levels Or Treating Anemia In A Patient
  • Myostatin Irna Compositions And Methods Of Use Thereof
  • For Modulating Growth Of A Tissue, Such As Bone, Cartilage, Muscle, Fat, And/Or Neuron; Comprising An Altered Growth Differentiation Factor 11 (Gdf11)-Binding Domain Of An Actrii Receptor
  • Actriib-Fc Polynucleotides, Polypeptides, And Compositions
  • Antagonist Antibodies Against Gdf-8
  • Follistatin Domain Containing Proteins
  • Methods Of Identifying Actriib Variants
  • Multi-Arm Polymeric Prodrug Conjugates Of Taxane-Based Compounds
  • Scaffolds For Cell Transplantation
  • Methods For Controlling Blood Pharmacokinetics Of Antibodies
  • Casting Process And Sand Mould Provided With An Inlet System For Producing At Least Partly Thin Walled Aluminium Casts With Sand Moulding Technology By Means Of Gravity Casting
  • Modified And Stabilized Gdf Propeptides And Uses Thereof
  • Growth Differentiation Factor-8
  • Methods Of Increasing Sarcolemmal Utrophin
  • Use Of Gdf Traps To Treat Anemia
  • Modified And Stabilized Gdf Propeptides And Uses Thereof
  • Guided Injections For Aav Gene Transfer To Muscle
  • Activin-Actrii Antagonists And Uses For Increasing Red Blood Cell Levels
  • Fcgammariib-Specific Fc Region Variant
  • Controlled Delivery Of Tlr3 Agonists In Structural Polymeric Devices
  • Methods Of Promoting Fat Loss Comprising Administering An Alk7 Inhibitor
  • Methods For Treating Ulcers In Thalassemia Syndrome With An Actriib Polypeptide
  • Actriib Proteins And Variants And Uses Therefore Relating To Utrophin Induction For Muscular Dystrophy Therapy
  • Neutralizing Antibodies Against Gdf-8 And Uses Therefor
  • Continuous Cell Programming Devices
  • Methods For Increasing Adiponectin In A Patient In Need Thereof
  • Moderate Cell Differentiation; Muscular Disorders; Fat Metabolism; Bone Disorders
  • In Situ Antigen-Generating Cancer Vaccine
  • Method Of Promoting Bone Growth By An Anti-Activin A Antibody
  • Method Of Identifying An Agent That Promotes Bone Growth Or Increases Bone Density
  • Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr
  • Antibody To Gdf8 And Uses Thereof
  • Antigen-Binding Molecule Capable Of Binding Two Or More Antigen Molecules Repeatedly
  • Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
  • Scaffolds For Cell Transplantation
  • Binding Agents Which Inhibit Myostatin
  • Methods For Increasing Thermogenic Adipocytes
  • Scaffolds For Cell Collection Or Elimination
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Activin-Actriia Antagonists And Uses For Treating Multiple Myeloma
  • Method For Treating Il-8-Related Diseases
  • Multi-Arm Polymeric Alkanoate Conjugates
  • A Nucleic Acid Molecule; Treatment Of Muscle Wasting Caused From Aging, Autoimmune Deficiency Syndrome, Multiple Sclerosis And Cancer
  • Method Of Eliciting An Anti-Tumor Immune Response With Controlled Delivery Of Tlr Agonists In Porous Polymerlc Devices
  • Antigenic Peptide Fragments Of Growth Differentiation Factor 8, And Related Immunogens, Vaccines; Immunization; Drug Screening
  • Activin-Actriia Antagonists For Inhibiting Germ Cell Maturation
  • Neutralizing Gdf8 Epitope-Based Growth Enhancing Vaccine
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
  • Muscle Regeneration
  • Having High Affinity And May Be Chimeric, Humanized Or Fully Human Antibodies, Immunoconjugates Of The Antibodies Or Antigen-Binding Fragments Thereof; Useful For Increasing Muscle Mass, Increasing Bone Density, Or For The Treatment Of Various Disorders In Mammalian And Avian Species
  • Double-Muscling In Mammals
  • Programming Of Cells For Tolerogenic Therapies
  • Methods For Altering Body Composition By Administering A Gdf8 Inhibitor And An Activin A Inhibitor
  • Polynucleotides Encoding Promyostatin Polypeptides
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Mouse Fcγammarii-Specific Fc Antibody
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Use Of Decorin For Increasing Muscle Mass
  • Nucleic Acids Encoding Neutralizing Gdf8 Epitope-Based Peptides And Fusion Proteins
  • Having High Affinity And May Be Chimeric, Humanized Or Fully Human Antibodies, Immunoconjugates Of The Antibodies Or Antigen-Binding Fragments Thereof; Useful For Increasing Muscle Mass, Increasing Bone Density, Or For The Treatment Of Various Disorders In Mammalian And Avian Species
  • Follistatin Variant Polypeptide
  • Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr
  • Transgenic Non-Human Animals Expressing A Truncated Activin Type Ii Receptor
  • Methods Of Treating Musculodegenerative Disease With An Antibody That Binds Growth Differentiation Factor-8
  • Anti-Myostatin Antibodies
  • Increasing Muscle Mass While Reducing Fat And Cholesterol Levels In Animal Food Products
  • Variants Derived From Actriib And Uses Therefor
  • Growth Differentiation Factor-8
  • Antagonist Antibodies Against Gdf-8 And Uses Therefor
  • Antibodies Against Growth And Differentiation Factor-8 (Gdf-8), Also Known As Myostatin, Including Fragments; Muscle And Bone Degenerative Disorders; Muscular Dystropy/Atrophy; Antidiabetic Agents; Congestive Obstructive Pulmonary Disease
  • Growth Differentiation Factor-8 Nucleic Acid And Polypeptide From Aquatic Species, And Transgenic Aquatic Species
  • Method For Decreasing The Body Fat Content In A Subject By Administering An Actriib Protein
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Scaffolds For Cell Collection Or Elimination
  • Method For Decreasing The Body Fat Content In A Subject By Administering An Actriib Protein
  • Actriia Binding Agents And Uses Thereof
  • Methods Of Promoting Fat Loss Comprising Administering An Alk7 Inhibitor
  • Growth Differentiation Factor-8
  • Methods And Compositions For Reducing Serum Lipids
  • Methods And Compositions For Treating Ulcers
  • Antagonist Antibodies Against Gdf-8 And Uses Therefor
  • Neutralizing Antibodies Against Gdf-8 And Uses Therefor
  • Truncated Actriib-Fc Fusion Protein
  • Myostatin Inhibition For Enhancing Muscle And/Or Improving Muscle Function
  • Antibody To Gdf8 And Uses Thereof
  • Oligomers
  • Actriib-Fc Polynucleotides, Polypeptides, And Compositions
  • Multi-Arm Polymeric Prodrug Conjugates Of Cabazitaxel-Based Compounds
  • Variants Derived From Actriib
  • Anti-Myostatin Antibodies
  • Increasing Muscle Mass While Reducing Fat And Cholesterol Levels In Animal Food Products
  • Antibodies To Human Gdf8
  • Nucleic Acids Encoding Neutralizing Gdf8 Epitope-Based Peptides And Fusion Proteins
  • Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr
  • Mouse Fcγammarii-Specific Fc Antibody
  • Having High Affinity And May Be Chimeric, Humanized Or Fully Human Antibodies, Immunoconjugates Of The Antibodies Or Antigen-Binding Fragments Thereof; Useful For Increasing Muscle Mass, Increasing Bone Density, Or For The Treatment Of Various Disorders In Mammalian And Avian Species
  • Follistatin Variant Polypeptide
  • Transgenic Non-Human Animals Expressing A Truncated Activin Type Ii Receptor
  • Methods Of Treating Musculodegenerative Disease With An Antibody That Binds Growth Differentiation Factor-8
  • Harnessing Cell Dynamics To Engineer Materials
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/387083a0

    DOI

    http://dx.doi.org/10.1038/387083a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1027453384

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9139826


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aging", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amino Acid Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Body Weight", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "CHO Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cloning, Molecular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cricetinae", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Embryo, Mammalian", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Targeting", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Homozygote", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hyperplasia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hypertrophy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "In Situ Hybridization", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred C57BL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Muscle, Skeletal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myostatin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Polymerase Chain Reaction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Sorting Signals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Stem Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transforming Growth Factor beta", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA", 
              "id": "http://www.grid.ac/institutes/grid.21107.35", 
              "name": [
                "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McPherron", 
            "givenName": "Alexandra C.", 
            "id": "sg:person.01317615613.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317615613.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA", 
              "id": "http://www.grid.ac/institutes/grid.21107.35", 
              "name": [
                "Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lawler", 
            "givenName": "Ann M.", 
            "id": "sg:person.0612727554.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612727554.84"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA", 
              "id": "http://www.grid.ac/institutes/grid.21107.35", 
              "name": [
                "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Se-Jin", 
            "id": "sg:person.0642324713.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642324713.59"
            ], 
            "type": "Person"
          }
        ], 
        "datePublished": "1997-05", 
        "datePublishedReg": "1997-05-01", 
        "description": "The transforming growth factor-\u03b2 (TGF-\u03b2) superfamily encompasses a large group of growth and differentiation factors playing important roles in regulating embryonic development and in maintaining tissue homeostasis in adult animals1. Using degenerate polymerase chain reaction, we have identified a new murine TGF-\u03b2 family member, growth/differentiation factor-8 (GDF-8), which is expressed specifically in developing and adult skeletal muscle. During early stages of embryogenesis, GDF-8 expression is restricted to the myotome compartment of developing somites. At later stages and in adult animals, GDF-8 is expressed in many different muscles throughout the body. To determine the biological function of GDF-8, we disrupted the GDF-8 gene by gene targeting in mice. GDF-8 null animals are significantly larger than wild-type animals and show a large and widespread increase in skeletal muscle mass. Individual muscles of mutant animals weigh 2-3 times more than those of wild-type animals, and the increase in mass appears to result from a combination of muscle cell hyperplasia and hypertrophy. These results suggest that GDF-8 functions specifically as a negative regulator of skeletal muscle growth.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/387083a0", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6628", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "387"
          }
        ], 
        "keywords": [
          "Growth/differentiation factor 8", 
          "wild-type animals", 
          "TGF-\u03b2 family members", 
          "degenerate polymerase chain reaction", 
          "adult skeletal muscle", 
          "skeletal muscle growth", 
          "GDF-8 expression", 
          "differentiation factor 8", 
          "embryonic development", 
          "tissue homeostasis", 
          "mutant animals", 
          "superfamily members", 
          "biological functions", 
          "negative regulator", 
          "null animals", 
          "muscle growth", 
          "skeletal muscle mass", 
          "factor 8", 
          "differentiation factor", 
          "genes", 
          "skeletal muscle", 
          "growth factor", 
          "muscle cell hyperplasia", 
          "polymerase chain reaction", 
          "family members", 
          "adult animals", 
          "muscle mass", 
          "important role", 
          "later stages", 
          "embryogenesis", 
          "animals", 
          "somites", 
          "chain reaction", 
          "regulator", 
          "growth", 
          "members", 
          "homeostasis", 
          "large group", 
          "regulation", 
          "widespread increase", 
          "mice", 
          "expression", 
          "compartments", 
          "early stages", 
          "animals1", 
          "muscle", 
          "function", 
          "stage", 
          "different muscles", 
          "role", 
          "factors", 
          "mass", 
          "increase", 
          "development", 
          "individual muscles", 
          "cell hyperplasia", 
          "body", 
          "hypertrophy", 
          "combination", 
          "results", 
          "group", 
          "reaction", 
          "time", 
          "hyperplasia"
        ], 
        "name": "Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member", 
        "pagination": "83-90", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1027453384"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/387083a0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9139826"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/387083a0", 
          "https://app.dimensions.ai/details/publication/pub.1027453384"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:30", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_296.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/387083a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/387083a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/387083a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/387083a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/387083a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    233 TRIPLES      20 PREDICATES      113 URIs      105 LITERALS      30 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/387083a0 schema:about N17ba710bf2fb47e891a0fe5dad2c80bc
    2 N232c5fb97c714109bdcb7cf360323493
    3 N2af42c6fbc694cdb8ddfcad0ac5d3ee5
    4 N3340b649b60845ebb4f08ea0df79d2ad
    5 N3973dc15962c453fa32031638bf3d57b
    6 N3c252c3ff46b4f3894746ebd8e063308
    7 N4460379640794d1fb819afa43df7af7e
    8 N521b2f24951940b096bac374743c2d34
    9 N61bb86007c6a430d879a5f8779e889b0
    10 N61f5f6ea59d340bd8ef22dd97e4ddc15
    11 N62230cf69aa547188e715ceb44b01533
    12 N90853f91b7b641a4989cf790cdeeddcb
    13 N9416c4372eea4b0cb48dd4b8a3229210
    14 Na0742b823c204e5db48d986b34165635
    15 Na2bdaffe0a1244c0987bc5e13c0952dc
    16 Nadf0890653b74dafb1ac282343e51777
    17 Naf291c50ee064f059fcd51ee5a5a6840
    18 Nc39589b7828e4bf0bc79f9dfd0ba8641
    19 Nc68aca65b4204639881011c211d32e04
    20 Ncd6f957f77b7424688af80725518610a
    21 Ncd9726586d3047f8bc4b56a82dbb6273
    22 Ne2f166f744db4bf9b1f16c4450dc9254
    23 Nff0244be6dc6456c85ac07ea25afb82a
    24 anzsrc-for:06
    25 anzsrc-for:0604
    26 schema:author Nebfe8a6bdf5c49d68edf9a4c4d26b71b
    27 schema:datePublished 1997-05
    28 schema:datePublishedReg 1997-05-01
    29 schema:description The transforming growth factor-β (TGF-β) superfamily encompasses a large group of growth and differentiation factors playing important roles in regulating embryonic development and in maintaining tissue homeostasis in adult animals1. Using degenerate polymerase chain reaction, we have identified a new murine TGF-β family member, growth/differentiation factor-8 (GDF-8), which is expressed specifically in developing and adult skeletal muscle. During early stages of embryogenesis, GDF-8 expression is restricted to the myotome compartment of developing somites. At later stages and in adult animals, GDF-8 is expressed in many different muscles throughout the body. To determine the biological function of GDF-8, we disrupted the GDF-8 gene by gene targeting in mice. GDF-8 null animals are significantly larger than wild-type animals and show a large and widespread increase in skeletal muscle mass. Individual muscles of mutant animals weigh 2-3 times more than those of wild-type animals, and the increase in mass appears to result from a combination of muscle cell hyperplasia and hypertrophy. These results suggest that GDF-8 functions specifically as a negative regulator of skeletal muscle growth.
    30 schema:genre article
    31 schema:isAccessibleForFree false
    32 schema:isPartOf N20e18271ac3d4688b6604c1ca9d9d84d
    33 N8b045ce619004be293dd80359ddf88c1
    34 sg:journal.1018957
    35 schema:keywords GDF-8 expression
    36 Growth/differentiation factor 8
    37 TGF-β family members
    38 adult animals
    39 adult skeletal muscle
    40 animals
    41 animals1
    42 biological functions
    43 body
    44 cell hyperplasia
    45 chain reaction
    46 combination
    47 compartments
    48 degenerate polymerase chain reaction
    49 development
    50 different muscles
    51 differentiation factor
    52 differentiation factor 8
    53 early stages
    54 embryogenesis
    55 embryonic development
    56 expression
    57 factor 8
    58 factors
    59 family members
    60 function
    61 genes
    62 group
    63 growth
    64 growth factor
    65 homeostasis
    66 hyperplasia
    67 hypertrophy
    68 important role
    69 increase
    70 individual muscles
    71 large group
    72 later stages
    73 mass
    74 members
    75 mice
    76 muscle
    77 muscle cell hyperplasia
    78 muscle growth
    79 muscle mass
    80 mutant animals
    81 negative regulator
    82 null animals
    83 polymerase chain reaction
    84 reaction
    85 regulation
    86 regulator
    87 results
    88 role
    89 skeletal muscle
    90 skeletal muscle growth
    91 skeletal muscle mass
    92 somites
    93 stage
    94 superfamily members
    95 time
    96 tissue homeostasis
    97 widespread increase
    98 wild-type animals
    99 schema:name Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
    100 schema:pagination 83-90
    101 schema:productId N1c0b4738079c4b8489dcd3877bb34ee1
    102 Nae60d3e453bb4cc5a03a23ffcef408a4
    103 Nb553349adfcc474fbddd950d5f442df7
    104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027453384
    105 https://doi.org/10.1038/387083a0
    106 schema:sdDatePublished 2022-10-01T06:30
    107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    108 schema:sdPublisher N977f0c90c19640d890863a95c4eca566
    109 schema:url https://doi.org/10.1038/387083a0
    110 sgo:license sg:explorer/license/
    111 sgo:sdDataset articles
    112 rdf:type schema:ScholarlyArticle
    113 N17ba710bf2fb47e891a0fe5dad2c80bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name Muscle, Skeletal
    115 rdf:type schema:DefinedTerm
    116 N1c0b4738079c4b8489dcd3877bb34ee1 schema:name doi
    117 schema:value 10.1038/387083a0
    118 rdf:type schema:PropertyValue
    119 N20e18271ac3d4688b6604c1ca9d9d84d schema:volumeNumber 387
    120 rdf:type schema:PublicationVolume
    121 N232c5fb97c714109bdcb7cf360323493 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Polymerase Chain Reaction
    123 rdf:type schema:DefinedTerm
    124 N2af42c6fbc694cdb8ddfcad0ac5d3ee5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Protein Sorting Signals
    126 rdf:type schema:DefinedTerm
    127 N3340b649b60845ebb4f08ea0df79d2ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Homozygote
    129 rdf:type schema:DefinedTerm
    130 N3973dc15962c453fa32031638bf3d57b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Transforming Growth Factor beta
    132 rdf:type schema:DefinedTerm
    133 N3c252c3ff46b4f3894746ebd8e063308 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Animals
    135 rdf:type schema:DefinedTerm
    136 N4460379640794d1fb819afa43df7af7e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Myostatin
    138 rdf:type schema:DefinedTerm
    139 N521b2f24951940b096bac374743c2d34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Humans
    141 rdf:type schema:DefinedTerm
    142 N61bb86007c6a430d879a5f8779e889b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name CHO Cells
    144 rdf:type schema:DefinedTerm
    145 N61f5f6ea59d340bd8ef22dd97e4ddc15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Hypertrophy
    147 rdf:type schema:DefinedTerm
    148 N62230cf69aa547188e715ceb44b01533 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Mice
    150 rdf:type schema:DefinedTerm
    151 N8b045ce619004be293dd80359ddf88c1 schema:issueNumber 6628
    152 rdf:type schema:PublicationIssue
    153 N90853f91b7b641a4989cf790cdeeddcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Stem Cells
    155 rdf:type schema:DefinedTerm
    156 N9416c4372eea4b0cb48dd4b8a3229210 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Aging
    158 rdf:type schema:DefinedTerm
    159 N977f0c90c19640d890863a95c4eca566 schema:name Springer Nature - SN SciGraph project
    160 rdf:type schema:Organization
    161 Na0742b823c204e5db48d986b34165635 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Cricetinae
    163 rdf:type schema:DefinedTerm
    164 Na2bdaffe0a1244c0987bc5e13c0952dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Gene Targeting
    166 rdf:type schema:DefinedTerm
    167 Nadf0890653b74dafb1ac282343e51777 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Amino Acid Sequence
    169 rdf:type schema:DefinedTerm
    170 Nae1ece5ca40b463fa9a4236020e36d24 rdf:first sg:person.0612727554.84
    171 rdf:rest Nc6a5eda3a1004815883d1681cdea0825
    172 Nae60d3e453bb4cc5a03a23ffcef408a4 schema:name pubmed_id
    173 schema:value 9139826
    174 rdf:type schema:PropertyValue
    175 Naf291c50ee064f059fcd51ee5a5a6840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Embryo, Mammalian
    177 rdf:type schema:DefinedTerm
    178 Nb553349adfcc474fbddd950d5f442df7 schema:name dimensions_id
    179 schema:value pub.1027453384
    180 rdf:type schema:PropertyValue
    181 Nc39589b7828e4bf0bc79f9dfd0ba8641 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name In Situ Hybridization
    183 rdf:type schema:DefinedTerm
    184 Nc68aca65b4204639881011c211d32e04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Mice, Inbred C57BL
    186 rdf:type schema:DefinedTerm
    187 Nc6a5eda3a1004815883d1681cdea0825 rdf:first sg:person.0642324713.59
    188 rdf:rest rdf:nil
    189 Ncd6f957f77b7424688af80725518610a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Molecular Sequence Data
    191 rdf:type schema:DefinedTerm
    192 Ncd9726586d3047f8bc4b56a82dbb6273 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Body Weight
    194 rdf:type schema:DefinedTerm
    195 Ne2f166f744db4bf9b1f16c4450dc9254 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Hyperplasia
    197 rdf:type schema:DefinedTerm
    198 Nebfe8a6bdf5c49d68edf9a4c4d26b71b rdf:first sg:person.01317615613.98
    199 rdf:rest Nae1ece5ca40b463fa9a4236020e36d24
    200 Nff0244be6dc6456c85ac07ea25afb82a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Cloning, Molecular
    202 rdf:type schema:DefinedTerm
    203 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    204 schema:name Biological Sciences
    205 rdf:type schema:DefinedTerm
    206 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    207 schema:name Genetics
    208 rdf:type schema:DefinedTerm
    209 sg:journal.1018957 schema:issn 0028-0836
    210 1476-4687
    211 schema:name Nature
    212 schema:publisher Springer Nature
    213 rdf:type schema:Periodical
    214 sg:person.01317615613.98 schema:affiliation grid-institutes:grid.21107.35
    215 schema:familyName McPherron
    216 schema:givenName Alexandra C.
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317615613.98
    218 rdf:type schema:Person
    219 sg:person.0612727554.84 schema:affiliation grid-institutes:grid.21107.35
    220 schema:familyName Lawler
    221 schema:givenName Ann M.
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612727554.84
    223 rdf:type schema:Person
    224 sg:person.0642324713.59 schema:affiliation grid-institutes:grid.21107.35
    225 schema:familyName Lee
    226 schema:givenName Se-Jin
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642324713.59
    228 rdf:type schema:Person
    229 grid-institutes:grid.21107.35 schema:alternateName Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    230 Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    231 schema:name Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    232 Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    233 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...